| #41 |
Venkatesh Nagesha |
Microsoft |
1 |
| #41 |
Anil K. Guntupalli |
Verizon |
1 |
| #41 |
Jessica E. Duda |
Aurora Flight Sciences |
1 |
| #41 |
James K.B. Nunn |
— |
1 |
| #41 |
Paul F. Fidlin |
Bose |
1 |
| #41 |
Lisa Jenzeh |
Verizon |
1 |
| #41 |
Steven O'Neil |
Dragonfly Therapeutics |
1 |
| #41 |
Wenfang Sybil Wu |
Berg Companies |
1 |
| #41 |
Aniruddha S. Weling |
Baker Hughes Oilfield Operations |
1 |
| #41 |
Niklas Andersson |
Boston Scientific Scimed |
1 |
| #41 |
Dilip Paithankar |
Candela |
1 |
| #41 |
Yunxiang Zhu |
Genzyme |
1 |
| #41 |
Xiaotian Zhong |
Pfizer |
1 |
| #41 |
David J. Vanslette |
— |
1 |
| #41 |
Claudia G. Wey |
The Mathworks |
1 |
| #41 |
Wildon Farwell |
Knopp Biosciences |
1 |
| #41 |
Kristine Canavan |
Analytics For Life |
1 |
| #41 |
Daniel P. Silver |
Dana-Farber Cancer Institute |
1 |
| #41 |
Qifeng Wei |
Koniniklijke Philips N.V. |
1 |
| #41 |
M.S. Sivasubramanian |
Cj Cheiljedang |
1 |
| #41 |
Richard Wiesman |
Foster-Miller |
1 |
| #41 |
Jurg Sommer |
Bioverativ Therapeutics |
1 |
| #41 |
Jochem Gokemeijer |
Bristol-Myers Squibb |
1 |
| #41 |
Xiaoye Jiang |
Emc |
1 |
| #41 |
Florian Schouten |
Numerify |
1 |
| #41 |
Gordon Wilkie |
Blueprint Medicines |
1 |
| #41 |
Alan J. Fenn |
MIT |
1 |
| #41 |
Thomas C. Michaud |
— |
1 |
| #41 |
Stanley J. Rosenthal |
Mevion Medical Systems |
1 |
| #41 |
William E. Hoke |
RTX (Raytheon) |
1 |
| #41 |
Vasudevan Nagalingam |
Bank of America |
1 |
| #41 |
Robert Michelson |
Butler Home Products |
1 |
| #41 |
Svetlana Patsenker |
Emc |
1 |
| #41 |
Adi Gilboa-Geffen |
Dots Technology |
1 |
| #41 |
Joe Salas |
Bioverativ Therapeutics |
1 |
| #41 |
Ermira Pazolli |
Eisai R&D Management Co. |
1 |
| #41 |
Nicholas Anthony Zafiropoulos |
Aspen Aerogels |
1 |
| #41 |
Jessica B. Schindler |
Us Government As Represented By The Secretary Of The Army |
1 |
| #41 |
Seldron D. Geziben |
Verizon |
1 |